Public Satisfying: Patient-Focused Drug Advancement for Fibromyalgia (Part 1 of 2)

On March 26, 2014, FDA hosted a public conference on Patient-Focused Drug Advancement for Fibromyalgia. FDA had an interest in getting client point of views on the effect of Fibromyalgia on life and client views on treatment techniques. For more details, check out the conference web page: https://www.fda.gov/industry/prescription-drug-user-fee-amendments/fda-led-patient-focused-drug-development-pfdd-public-meetings#fibromyalgia

http://medicaltranscriptionprograms.com/public-satisfying-patient-focused-drug-advancement-for-fibromyalgia-part-1-of-2/